Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries (formerly Sun Techno Overseas Limited) has submitted the notice for its 30th AGM, scheduled for Thursday, 25th September 2025 at 4:00 PM via video conferencing. Shareholders will consider adopting the FY25 audited financial statements and reappointing M/s. Rishi Sekhri and Associates as statutory auditors for a term up to the AGM in 2030. Two special items seek approval for the appointment of Mr. Kelash Bunkar as Whole Time Director & CFO (for 3 years on nil remuneration) and Mr. Aman Patel as Independent Director (for 5 years up to September 2030). The company is also seeking shareholder approval to raise its borrowing limit and its investments/loans/guarantees limit to Rs. 100 crore each, citing growth in business operations.
Routine procedural filing ahead of the AGM. The proposed 100 crore borrowing and investment limits are significant relative to the company's size and signal intent to expand or raise debt, but no immediate share-price catalyst is expected. Both director appointments are on nil remuneration and neither director holds any shares in the company.